Frazier Life Sciences

Frazier Healthcare Partners is a Seattle, Washington-based private equity and venture capital firm founded in 1991 by Alan D. Frazier, with additional offices in Menlo Park, California, and New York, New York. The firm invests exclusively in the healthcare sector and has raised more than USD 11 billion in total capital across its history, having backed over 200 companies. Frazier operates through two principal strategies: a Growth Buyout team that invests in profitable U.S. middle-market healthcare services and pharmaceutical-services businesses, and a Life Sciences team (Frazier Life Sciences, frazierls.com) that invests in private and public biopharmaceutical companies developing novel therapeutics, having closed a USD 1.3 billion twelfth life-sciences fund in 2024. Investment geography spans the U.S., Canada, and Europe, and disclosed portfolio companies include Calistoga Pharmaceuticals, Knipper Health, and over 500 logged investments to date.